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Abstract: The toxin ricin has long been understood to have potential for criminal activity 
and there has been concern that it might be used as a mass-scale weapon on a military basis 
for at least two decades. Currently, the focus has extended to encompass terrorist activities 
using ricin to disrupt every day activities on a smaller scale. Whichever scenario is 
considered, there are features in common which need to be understood; these include the 
knowledge of the toxicity from ricin poisoning by the likely routes, methods for the 
detection of ricin in relevant materials and approaches to making an early diagnosis of ricin 
poisoning, in order to take therapeutic steps to mitigate the toxicity. This article will review 
the current situation regarding each of these stages in our collective understanding of ricin 
and how to defend against its use by an aggressor.  
Keywords: toxicology of ricin; inhalation; parenteral (intramuscular); ingestion; detection; 
antibody based tests; mass spectrometry; polymerase chain reaction 
 
1. Introduction 
The protein toxin, ricin, is effectively a bi-product of the castor oil extraction process and at least 
100 million metric tonnes of castor beans are grown and processed every year with the purpose of 
preparing castor oil. In addition to cultivation for oil production, the Ricinus plant also grows like a 
weed in warmer climates of the world, including Africa, the Middle East, India and Southern France. 
A highly toxic preparation may fairly easily be produced from castor bean seeds and recipes have been 
circulated on the internet [1–4] and in manuals that would assist the would-be terrorist. The terrorist 
“cookbooks” have been examined by Pita and Domingo [5] and, in the case of ricin, deemed incapable 
of achieving a good product for causing a large number of casualties by any exposure route, mainly 
because of the low content of toxin of the final extracts. It is a large step from preparing a poisonous 
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mixture from castor beans, to delivering this material in a suitable form, on a large enough scale, to 
cause harm to a number of target subjects. Ricin is harmful and can have potentially lethal 
consequences when delivered by several routes, including those which are considered relevant to 
military or terrorist scenarios, namely inhalation, parenteral administration (e.g., transdermal,   
sub-cutaneous or intramuscular) or by ingestion. However, the toxicity of the toxin may be very 
different depending upon the route of intoxication. Franz and Jaax [6] have presented a collection of 
toxicity assessments for ricin pertaining to different routes of exposure based on studies in mice. The 
toxicity of ricin in mice causing death in 50% of the target population (LD50) by inhalation is given as 
3–5 μg kg
−1 with a mean time to death of 60 h; 24 μg kg
−1 and death in 100 h by subcutaneous 
injection and 20 mg kg
−1 and death in 85 h by ingestion. The main lesion caused by ricin is impairment 
of the protein synthesis machinery of the cell [7] but, in the living organism, a number of symptoms 
arise leading to an overall picture of ricin intoxication. In the following section, the toxicity, signs and 
symptoms of ricin poisoning will be examined, as far as is possible, by route of intoxication.  
If ricin were released in an attack, it is essential that the toxin is detected on materials and this 
might entail extremes such as sampling soil to foodstuffs, particularly if contamination of foods had 
been threatened. As a result of this risk, a considerable amount of work has been undertaken over the 
past few years to develop detection methods for ricin in a range of substrates. The detection of ricin 
will be examined, giving a flavour of methods attempted and limits of detection achieved.  
Finally, the ability to diagnose exposure to ricin toxin is an important prelude to subsequent 
therapy, time being of the essence. Attempts currently underway that inform the diagnosis of ricin 
poisoning will be examined. 
2. Inhalation of Ricin 
Using a Liu-Lee aerosol generator [8], which produces a tight mass median aerodynamic diameter 
(MMAD) aerosol particle of just below 1 μm, Porton Wistar rats, (mean bodyweight 220 g) were 
exposed to aerosols generated from solutions of two different preparations of pure ricin. Ricin 
prepared from the Hale Queen variety of the castor oil plant was obtained commercially (Sigma) while 
the second was prepared in house from seeds of Ricinus communis var. zanzibariensis. Aerosol 
exposure times and solution concentrations were varied to achieve a range of exposure doses (the 
product of aerosol concentration, C, and time, t; Ct has units of mg min m
−3). It is conventional in 
inhalation toxicology to express (lethal) challenges as the product of C and t, rather than as lethal dose 
(LD). This is because the actual dose retained in the lungs is often uncertain and many studies do not 
attempt to calculate the actual retained fraction of the inhaled aerosol. The details of sample 
preparations, exposure conditions and subsequent inhalation toxicity data have been published in   
full [9]. The LCt50 values determined for the toxicity of the two preparations were different, being 
between 4.54 and 5.96 mg min m
−3 (estimated LD50 3.7 μg kg
−1) for Hale Queen and 12.7 mg min m
−3 
(estimated LD50 9.8 μg kg
−1) for zanzibariensis. Differences in toxicity are assumed to be based on 
variations in the isotoxins of ricin expressed by the different seed types. Subsequent analysis of ricins 
extracted from different castor seed cultivars, using 2D polyacrylamide gel electrophoresis and silver 
staining, has revealed differences in the range of ricin toxins expressed, based upon isoelectric   
points [10]. At supralethal doses, an inverse relation has been found between times to death and Ct [9], 
varying from about 36 h at higher Cts (for Hale Queen ricin, 119.3 and 11.9 mg min m
−3) to 66 and Toxins 2011, 3 
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138 h at lower Cts (Hale Queen, 4.54 and 5.96 mg min m
−3). A similar Ct: time to death relationship 
was found for R. zanzibariensis  and also for abrin, in which the LCt50 was found to be   
4.54 mg min m
−3 (estimated LD50 3.3 μg kg
−1). 
Particles of around 1 μm would be expected to flow with the airstream around obstacles such as the 
nasal turbinates, rather than impact through inertia, and reach the deep lung. Roy et al. [11] examined 
the comparative distribution of inhaled aerosolized ricin particles of different size ranges of 1 μm and 
5–12 μm MMAD. This study showed that in mice exposed nose-only to aerosol, ~60% of the 1 μm 
ricin particles were deposited in the lungs, followed by the trachea, with very small amounts (~1–2%) 
being measured (ELISA) in nares and stomach. At the larger particle sizes, most ricin was found to be 
in the trachea, with less in the lungs (~20%); very little ricin was found in the nares (1–8%) and 
stomach. It was rather surprising that so little of the larger sized ricin particles were filtered out by the 
nares. The authors felt that the heterogeneous size distribution of the larger particles and poor control 
of the dispersion of particles, partly due to restrictions imposed by working in Class III safety cabinets, 
may have influenced regional distribution patterns and subsequent ricin distribution rates. The 
influence of particle size on lethality was marked, in that those animals which received a supra-lethal 
dose of 1 µm particles of ricin died at 72 h post-exposure, whereas those receiving a similar challenge 
of larger particles (>5 µm) all survived. 
The body distribution of inhaled ricin was examined by Deobler et al. [12]. They exposed mice 
nose-only to aerosolized (1 μm MMAD) 
125I-ricin and found radiolabel in the lungs but also in the 
gastrointestinal tract, although release into the circulation was found to be minimal. It is reasonable to 
assume that some inhaled aerosol would be swallowed, although it is unlikely that it would contribute 
significantly to the lethality of the total dose received since the oral toxicity of ricin is very much lower 
than that of the inhaled toxin. In the mouse, the inhaled LD50 was cited as being between 3 and  
5 μg kg
−1 whereas the comparative lethality by ingestion is 20 mg kg
−1 (6).  
The largest quantity of 
125I-ricin was found in the lungs, being highest at 15 min post-exposure, 
declining by around 50% in the first four hours after exposure and then dissipating from the lungs 
much more slowly between four and thirty hours, thereafter. Radioactivity was also measured in the 
stomach, spleen and liver; it was also found in the blood, with as much as approximately 600 pg of 
ricin equivalent label being measured here at times between one and eight hours pose-exposure. 
Inhalation toxicity studies of ricin have been undertaken by other laboratories where the mouse was 
the small animal model of choice, although different strains have been used. For example, Balb/c mice 
were challenged by inhalation using whole body exposure to pure ricin (variety of origin not   
given) [13] and an LD50 of 11.2 μg kg
−1 was determined, which agrees well with the data we found in 
inhalation studies in the rat for ricin extracted from R. zanzibariensis. Differential susceptibilities to 
inhaled ricin were also mentioned in relation to mouse strain and the LD50 for inhaled ricin in the most 
sensitive strain, BXSB, was approximately 2.8 μg kg
−1. It was also intimated by these authors, that the 
toxicities of different sources of ricin can vary, an observation which we made from our own inhalation 
toxicity studies in the rat between ricins originating from Hale Queen and R. zanzibariensis (above).  
Recently, ricin isoforms of similar molecular weights, were purified using a standard approach [14] 
and resolved using lactamyl-sepharose to reveal molecules of very different toxicities using in vitro  
(in Vero cells) and in vivo (in mice) techniques [15]. One isoform, RIII, representing 35% of the ricin 
isoforms in the seed [16], was substantially more toxic (4–8 fold) than the others; the presence of a Toxins 2011, 3 
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higher proportion of this isoform in ricin produced by an cultivar of Ricinus communis, could go some 
way to explain the different toxicity values measured for Hale Queen and zanzibariensis. It was also 
the most heavily N-glycosylated isoform, bearing 22 glycopeptide fragments compared with whole 
ricin, which was found to contain 25; the sugars were mainly hybrid/complex type with mannose, as 
the hexose sugar units [16].  
A very recent study by Benson et al. [17] examined the acute toxicity of ricin, associated 
histopathology, deposition and clearance kinetics in rats and mice. The study determined that the 
estimated mean lethal dose for ricin in rats was 0.24 μg kg
−1 and for mice, 0.58 μg kg
−1 with survival 
times ranging from ≤2 to 6.2 days in rats and from 2 to 7 days in mice, depending on dose (shorter 
times to death as concentration increased). These lethality figures suggest a potency of ricin some   
15–40 times higher in the rat depending on the source of ricin (from Hale Queen or zanzibariensis) and 
are between 5 and 19 times higher in the mouse than figures determined before [9,14]. This may be in 
part due to the calculation of deposited dose in this study [17] which involved the incorporation of a 
“deposition fraction” into a calculation combining aerosol concentration (C), minute volume of the 
animals (MV), exposure time (t), (µg ricin deposited = µg ricin/L air (C) × MV × t × deposition 
fraction. The latter was derived by Schlesinger in 1985 [18]. Our observations [9] were based on the 
concentration (C) of ricin aerosolized, time of exposure (t) and inhaled using minute volumes (MV) 
without the introduction of a deposition fraction.  
In a recent ricin inhalation study in mice [19], we used a head only delivery of 1 μm MMAD 
aerosol particles and measured ricin by ELISA in tissue extracts. We found majority of the toxin to be 
present in the lungs, smaller quantities of ricin in the liver but also small amounts in the heart, kidney 
and some lymphoid tissues. No ricin was at any time found in the blood or gastro-intestinal tract using 
the ELISA. It is possible that Doebler et al. [12] were picking up radio-iodine rather than ricin in the 
blood and that, in our study, swallowed and denatured ricin was not picked up by the antibodies used 
in our ELISA.  
Histopathology of Intoxication  
Histopathology resulting from the aerosol exposures of rats to ricin extracted from Hale Queen and 
R. zanzibariensis cultivars of Ricinus communis plants confirmed that ricin particles reached the deep 
lung. Animals were exposed (and culled over a time course of up to 14 days) by inhalation to aerosols 
of either type of ricin of particle size <1 μm at similar Ct levels (LCt30). The pathogenesis of damage 
resulting from the inhalation of aerosols of both varieties of pure ricin were broadly similar and were 
found to be confined to the lungs [9]. At two days post-exposure, pathological changes to the lung 
included necrosis, as well as apoptotic deletion of the epithelia of the bronchi, segmental bronchioles 
and the terminal bronchioles. A well established acute alveolitis was present with severe interstitial 
(perivascular) and intra-alveolar oedema, with an excess of apoptotic body formation. Macrophages 
were present within the interstitial alveolar septae. The upper airways were lined by intact,   
non-inflamed epithelium and extra-pulmonary organs were histologically normal.  
At three days post-exposure, the dominant feature was an overwhelming diffuse alveolar oedema, 
established acute alveolitis with severe capillary congestion and infiltration of the pulmonary interstitium 
by large activated macrophages. Careful examination also revealed small focal, sometimes florid areas 
of type II pneumocyte hyperplasia. The large airways continued to demonstrate necrosis of the lining Toxins 2011, 3 
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epithelia but there was also evidence of early epithelial regeneration. By four days the histological 
picture was dominated by rapidly resolving pulmonary oedema and general pulmonary consolidation 
by small lymphocytes, activated macrophages and a striking proliferation of type II pneumocytes. By 
this time, the bronchioles and bronchi were completely re-epithelialised with lumina free-from oedema 
fluid, which had been present at two and three days. In keeping with the significant consolidation of 
the lung parenchyma (and hence an increase in pulmonary vascular resistance), the solid peripheral 
organs all showed severe passive venous congestion. By seven days post-exposure, multifocal but 
extensive islands of persistent consolidation were apparent, with all features described above at four 
days. Between the islands of consolidation, the lung tissue approached a normal appearance with 
complete absence of interstitial/intra-alveolar oedema and residual acute/chronic alveolitis. 
Fourteen days after exposure to ricin, all animals appeared to be essentially normal, except for a 
few focal areas of persistent intra-alveolar foamy (lipid-laden) macrophage infiltration. 
In essence, ricin damages the pulmonary epithelial cells which form part of the alveolae, causes 
inflammation, which leads to pulmonary flooding with oedema fluid; if damage is severe (if the dose 
of ricin inhaled is large enough), the victim effectively drowns. Damage was limited to the lung and 
the other organs examined remained normal in appearance.  
Using electron microscopy, Brown et al. [20] observed the initiation of oedema formation, initially 
perivascular, from 12 h following inhaled ricin aerosol (LCt30). The situation progressed from   
15–36 h to include interstitial and intra-alveolar regions. Additionally, inflammatory cell infiltration 
was evident from 12 h post challenge but the greatest numbers of macrophages and polymorphonuclear 
leucocytes were noted between 24 and 48 h. 
The epithelia of both the lower respiratory tract and the alveoli were subject to destructive 
inflammatory damage, with evidence of necrotic and apoptotic processes. Signs of repair were also 
noted in the form of hyperplasia of type II epithelial cells. Beyond 96 h, a gradual clearing of oedema 
fluid was observed although complete resolution of damage was not achieved until 14 days 
post exposure.  
The study by Benson et al. [17] also observed deposition in the nasal cavities and respiratory tracts 
of the rodents, where the increasing dose of ricin in rats was accompanied by more damage. In mice, 
greater damage in the tract occurred at later times as the lesion had more time to develop. In this study, 
the degree of pulmonary oedema was not apparently as great as that reported before [9], although 
inflammatory pulmonary lesions were observed as in the earlier studies. However, these lesions were 
more severe in animals which survived longer [17], and type II alveolar hyperplasia was noted in the 
repairing lungs. This study also reported thymic lesions (thymocyte apoptosis in rats and atrophy 
secondary to loss of cortical thymocytes in mice dying from ricin exposure) and splenic neutrophilic 
inflammation accompanied by lymphocytic and haematopoietic cell apoptosis.  
Wong  et al. [21] instilled doses of ricin, which were very high (supralethal) or sub-lethal   
(2–5 μg·100 g
−1), into the tracheae of mice and observed effects on pulmonary and extra-pulmonary 
tissues. At the higher dose (20 μg·100 g
−1), histopathological lesions were observed after 48 h and 
included perivascular and peribronchial oedema, disruption or denudation of the bronchial epithelium 
with evidence of haemorrhage, neutrophilia in bronchial and alveolar areas and apoptotic bodies. 
Fibrin was found to have deposited abundantly throughout the lungs of mice following ricin exposure 
(20 μg·100 g
−1), in particular within the microvasculature of the alveolar septa. Typically, lesions were Toxins 2011, 3 
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seen to be patchy, consistent with instillation, as compared with the more uniform distribution seen 
after inhalation of ricin. Proinflammatory transcripts ERK and JNK were activated (phosphorylated) in 
bronchial and bronchiolar epithelial cells, alveolar epithelial cells and endothelial cells (using 
immunoblotting for phospho (p)-ERK, p-JNK, p-p38 MAPK and p38 MAPK in lung wash lysates or 
immunohistochemical staining in lung sections of control or ricin-treated mice); a commensurate 
activation of NF-κβ was observed in most lung cells 48 h after ricin instillation. The presence of the 
apoptotic marker, caspase 3, was found throughout the lungs in patches of airway cells and scattered 
cells in the alveolar parenchyma in mice exposed to ricin. Microarray analysis confirmed a   
ricin-induced elevation of cytokines and chemokines (TNF-α, IL-6, IL-1β, CXCL1 and CCL2) in 
mouse sera, as well as increased expression of proinflammatory transcripts in lung and other tissues. 
Of particular interest was the finding that 28S rRNA lesions could be detected in kidney tissue and 
other organs (lungs, spleen, liver and blood) taken from ricin-instilled mice and a mild accumulation of 
inflammatory cells after instillation of 20 μg·100 g
−1 ricin. Impaired kidney function (implied by the 
appearance of serum albumin in urine and increased blood urea nitrogen) accompanied the glomerular 
pathology observed. Observations indicated that instilled ricin accessed the circulation and it was 
shown that the same dose administered into the oesophagus (ingestion) did not access the circulation 
or other organs. This study is of interest in that it suggests that intra-pulmonary ricin does enter the 
blood and causes damage in other systemic organs. It is important to note that the doses of ricin 
administered were very high indeed; the so called “sub-lethal” dose of 2–5 μg·100 g
−1 translates to  
20–50 μg kg
−1. We instilled 2 μg kg
−1 of ricin into rats and found it to be supra-lethal [22]. The higher 
dose used in this study (20 μg·100 g
−1) would translate to 200 μg kg
−1, which is an extremely high dose 
of ricin; this might explain why damage to remote tissues was observed following administration of 
such a quantity of the toxin.  
The United States Army Medical Research Institute of Infectious Diseases is one of very few 
institutes to have undertaken inhalation toxicology studies with ricin in non-human primates. They 
studied two non human primate species, the rhesus monkey and the African Green monkey; lethal 
doses of ricin were determined to be 15 and 5.8 μg kg
−1, respectively, using the staircase method [13]. 
These inhalation LD50 estimates are of similar order to those found in the rat for ricin derived from  
R. zanzibariensis. Recent information has been obtained [23] that indicates that the LD50 by inhalation 
of ricin (pure ricin extracted from R. zanzibariensis) was around 5 μg kg
−1 in the rhesus macaque, 
which was close to the figure obtained for the African Green monkey. Histopathology was examined at 
death (36–40 h) following inhalation of supralethal doses of ricin aerosol (approximately 21 to   
42 μg kg
−1) in the rhesus monkey [24] and found to resemble closely that seen in the rat. Lesions were 
confined to the thoracic cavity with diffuse necrosis and acute airways inflammation with alveolar 
flooding and peribronchovascular oedema. Inflammation was also widespread in the trachea, the 
pleura and mediastinal lymph nodes. Similar findings in the African Green monkey were reported by 
Wannamacher et al. [13] where the lungs from ricin exposed animals exhibited haemorrhagic congestion 
and moderate multifocal bilateral oedema. Pathology was confined to the lungs and included 
fibrinohaemorrhagic pneumonia, alveolar and sometimes bronchiolar oedema, with necrotic changes to 
alveolar and bronchiolar epithelia. The authors concluded that the consistency in pathology between 
rodents, other reported species and non human primates adds confidence in predicting a similar picture 
in human victims of inhaled ricin.  Toxins 2011, 3 
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The major problem caused by the inhalation of these toxins seems to be pulmonary flooding of the 
lungs resulting from primary damage to epithelial and, presumably, underlying blood vessel endothelia. 
Damage is probably exacerbated by the massive inflammatory response mounted by the host to the 
presence of the toxin and the primary damage caused. Together, these events lead to respiratory 
insufficiency which, in severe cases, leads to death. 
There are no human cases of inhaled ricin to report but studies in rodents and non-human primates 
would indicate that symptoms of poisoning by this route of intoxication would be a gradual feeling of 
lassitude and loss of interest in the surroundings. Respiratory symptoms including wheezing and 
increased difficulty in breathing and tightness of the chest as lungs became oedematous would 
gradually increase from 24 h (after a fatal dose of ricin), with loss of appetite. Death occurs with 
anoxic convulsions, when it is impossible to obtain sufficient oxygen for brain function. Overall, ricin 
is very toxic by inhalation of particles small enough to reach the deep lung, where it causes disruption 
to alveolar epithelial membranes leading to pulmonary flooding and inflammation; this is a constant 
feature across species. Whether inhaled ricin enters the blood in sufficient quantity to cause damage in 
peripheral organs is still uncertain. Understanding the consequences of exposure to ricin by this route 
is very important in attempting to limit damage and prevent lethality. 
3. Toxicity of Ricin by Parenteral (Intramuscular) Administration 
Although ricin poisoning by intramuscular, subcutaneous or intravascular routes are relevant to 
military and terrorist attack scenarios these have been poorly investigated. Ricin could certainly be 
administered on a larger scale by skin penetration and into muscle, by explosive devices containing 
sharp materials such as flechettes coated with the toxin. Then, the introduction of the toxin into the 
body would probably involve a mixture of the three routes listed. On an individual basis, Georgi 
Markov was murdered in 1978, by the introduction of a toxin, probably ricin, from a small hollow 
pellet fired into his leg from a gas gun which was disguised as an umbrella [25,26]. Symptoms 
included pain at the injection site of the pellet followed by nausea, vomiting, fatigue and fever 
developing over the 24 h after injection. Gastrointestinal haemorrhage, hypovolaemic shock and renal 
failure developed subsequently and Markov died three days after being shot with the pellet.  
In studies on intramuscularly-administered ricin, we found that the LD50 by this route was between 
3 and 5 μg kg
−1 in the rat, with death occurring at between 36 and 48 h. We have also investigated the 
fate of radio-iodinated ricin administered intramuscularly into the thigh muscle of rats [27]. In interpreting 
distribution of ricin by virtue of this radiolabel, the same reservation of a possible separation between 
some label and ricin must be borne in mind. During intervals over a 30 hour period following 
administration, radioactivity was found to accumulate in lymph nodes draining the muscle, in the liver 
and other tissues. Using ELISA, it was possible to identify ricin in the lymph nodes and liver [28] and 
the toxin could be localised in these nodes using immunocytochemistry [29]. Closer examination of 
the lymph draining process suggested that ricin reached the lymph node an hour or so after injection 
and was bound to different cell types including lymphocytes by a mechanism which could be inhibited, 
in vitro, by lactose [30]. Damage to the small intestine was a feature following i.m. poisoning with 
ricin, with the infiltration of plasma cells and activated macrophages into the lamina propria and 
apoptotic deletion of these and structural cells in the ileum [31].  Toxins 2011, 3 
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When ricin is administered into the body in this way, and is able to enter the blood circulation, then 
it potentially has access to all systemic organs. The distribution of ricin would have a similar fate to 
that administered intravascularly but the time to effect would be expected to be slower following 
intramuscular administration.  
Ramsden et al. [32] observed the toxicity, distribution and excretion of ricin in rats, focusing on 
125I-labelled ricin. After intravascular administration, radioactivity distributed rapidly by 0.5 h to the 
liver (46%) and spleen (13%), although the concentration per g of tissue was highest in the spleen 
(33% of injected dose/g, 4 times that found in the liver). Loss of ricin from the liver was rapid (from 
about 40% of injected dose to less than 10% in 6 h). Radiolabel was detected also in the bone marrow, 
lung, kidney, heart, gut, lymphoid tissue, blood and muscle. Excretion of material was primarily via 
the kidneys in the urine and approximately 70% of the initial radioactivity was detected here within  
24 h, present in freely dialysable metabolites of ricin. Faecal excretion of ricin only accounted for 
about 2% of the injected dose.  
Histopathology of Intoxication  
Histopathology of ricin poisoning by the intramuscular route has not been very extensively 
investigated. Information is bolstered by evidence from the only reported case of human poisoning, 
that of Georgi Markov [25]. From the pellet which was introduced into his thigh muscle, ricin was 
distributed around his body, and many tissues were affected. Damage included the presence of severe 
local lymphoid necrosis (in the inguinal lymph nodes which drained the injection site), liver necrosis, 
diffuse inflammation of the kidneys and spleen. Haemorrhagic necrosis of the small intestine was also 
noted as well as the pancreas and testes. The myocardium and conducting tissues were found to have 
petechial haemorrhages which also featured in adrenals, gut wall and lymph nodes. A mild pulmonary 
oedema observed was thought to have been secondary to cardiac failure.  
The key feature of toxicity via the intramuscular/intravascular route is the fairly rapid distribution 
of toxin around the body to most organs, making therapeutic treatment a challenge.  
4. Ingestion of Ricin 
Oral toxicity of ricin has also been relatively poorly studied. In humans, there have been many 
attempts at suicide or inadvertent poisoning through eating castor oil seeds.  
Much more ricin is required to achieve lethality by the oral route as the toxicity of ricin when 
delivered this way is much lower than by inhalation and parenteral delivery routes. It has been noted 
that in the relatively few studies of oral intoxication by ricin, the precise means of dosing with the 
toxin (e.g., by mouth or by gavage) have been omitted. In the mouse the LD50 for orally administered 
ricin is quoted by Franz and Jaax [6] as 20 mg kg
−1 bodyweight with a time to death of approximately 
85 h. The lower toxicity by this route is probably a reflection of the poor absorption of ricin from the 
intestine. Kumar et al. quoted an LD50 value for male Swiss Albino mice [33] of 28.29 mg kg
−1.  
In another review by Audi et al. [34], the LD50 of ricin by the oral route was reported to be   
30 mg kg
−1 and a human LD50 estimate was given as 1–20 mg ricin kg
−1 bodyweight.  
While there have been many reported suicide attempts through the ingestion of castor oil seeds, 
there is great difficulty in the interpretation of the toxic dose because of variables including differences Toxins 2011, 3 
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in ricin content of seed types (e.g., geographic region of plant growth, time of harvesting seeds, degree 
of hydration of seeds and ricin isotoxin content) size and weight of seeds ingested as well as the degree 
of mastication to release the seed contents, including the water-soluble ricin.  
Victims of oral ricin poisoning feature prominent gastrointestinal symptoms which may include 
colicky abdominal pain, vomiting, diarrhoea, heartburn and oropharyngeal pain. In addition, 
haematemesis and melena (black tarry faeces associated with gastrointestinal haemorrhage) are less 
commonly-reported symptoms. Fluid loss may result in electrolyte imbalance, dehydration, 
hypotension and circulatory collapse [33]. Associated symptoms may include tachycardia, tachypnoea, 
sweating and peripheral cyanosis [35].  
A small study on the ingestion of ricin in Balb/c mice was undertaken in our laboratory which 
served as a control for a larger experiment. Groups of three mice were administered (by gavage) 10 or 
20 mg kg
−1 of ricin purified from Ricinus zanzibariensis seeds. Animals appeared normal over a 7 day 
period following oral dosing with 10 mg kg
−1. Forty-eight hours after dosing with 20 mg kg
−1 ricin, 
however, all mice were relatively inactive, they had lost the inquisitive habit typical of rodents and 
their fur was piloerected. One animal died on the fourth day and the stomach and small intestine 
showed evidence of inflammatory reddening of the small intestinal wall, close to its point of exit from 
the stomach. From this very limited study, the LD50 of pure ricin (from Ricinus zanzibariensis) in the 
mouse concurred well with other reported data [6], at around 20 mg kg
−1 (unreported observations).  
Ishiguro et al. [36] administered ricin (10 mg kg
−1) orally to rats, mixed into olive oil (precise 
method not given). About 40% of the administered ricin moved to the large intestine from the stomach 
within 12 h where it remained for at least 72 h, about 20% being excreted in the faeces. Ricin was 
found in lymph after 1 h, but entered the plasma, largely intact, more slowly, being maximal at around 
4 h. Transfer to the blood was probably a consequence of the damage inflicted on the intestine by the 
toxin. Using enzyme-immunoassay, ricin was detected in liver at 6 h, increasing over 48 h when it 
peaked at 95 ± 20 μg/organ. Ricin appeared in spleen after 3 h and was maximal at 6 h   
(0.1 ± 0.025 μg/organ), remaining constant to 72 h. Ricin could not be measured in pancreas, kidney, 
lung, heart and brain.  
Godal et al. [37] investigated the opportunity of radioimmunoassay to detect ricin (and abrin) in the 
blood and achieved a limit of detection of 50–100 pg mL
−1 with the inconvenience of having to deal 
with radioactive labels. Cook et al. [38] used a sensitive ELISA for ricin (or ricin-equivalent material, 
i.e., peptides or degraded ricin) in samples taken at 24 h after poisoning with 8 mg ricin/kg in the 
Porton Wistar rat. Ricin was detected in blood, in association with the cellular fraction (1.4 ng per  
2 mL sample), in liver tissue (9.5 ng g
−1), gut (stomach plus proximal duodenum; 31.7 ng g
−1), spleen  
(39.6 ng g
−1) and kidney (10.9 ng g
−1). In the case of the kidney, the signal was not significantly 
different from the corresponding vehicle assay. Comparison between the findings of this study with 
those of Ishiguro et al. [36] are qualitatively similar but quantitatively, levels of ricin (equivalent) 
detected would seem to be much smaller, reported in ng/g rather than μg/organ. 
Essentially, ingested ricin finds its way fairly rapidly into the blood and then to other tissues within 
a few hours of poisoning.  Toxins 2011, 3 
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Histopathology of Intoxication  
Histopathology of lethal cases of oral ricin intoxication includes multifocal, often severe, ulceration 
and haemorrhage of the gastric and small intestinal mucosa accompanied by necrosis of the draining 
mesenteric lymph nodes, gut associated lymphoid tissue and spleen. Necrosis is observed in liver 
tissue, especially the reticulendothelial Kupffer cells and diffuse inflammation of renal tubules 
(nephritis) and the spleen [6]. Apoptotic cell death is also cited in the histopathology of ricin toxicity 
by ingestion [34]. 
5. Detection of Ricin 
The detection of ricin in samples, including body tissues and many other materials, which may 
necessarily be examined has followed several lines of investigation. Clearly, it is most important to 
determine whether a person has been exposed to a chemical/biological agent in order to initiate 
appropriate therapeutic medical treatment, but it is also necessary to forensically determine exposure in 
order to attribute blame, from a legal viewpoint. It is also very much in the minds of various authorities 
that ricin might be used by terrorists to contaminate foods; it is, therefore, necessary to have the 
technical means to demonstrate whether such an action has been undertaken. From a defensive stance, 
there has been an upsurge in the development of assays to identify ricin and other toxins of concern, in 
body tissues and foods, but also in other matrices. Many approaches have been based on antibody 
recognition, with a number of strategies applied to increase sensitivity; these have been packaged in a 
variety of formats including the enzyme-linked immunosorbent assays (ELISAs), with various means 
of visualising the target, lateral flow devices, immunoaffinity columns or surface plasmon resonance 
(resonant mirror devices). A second approach, particularly applicable to instances where crude ricin 
preparations are involved, is the use of PCR to detect DNA or RNA relevant to the toxin or its plant 
origins. A third approach has been that of mass spectroscopy, for the identification of ricin or peptide 
components of the holotoxin. A fourth approach is that based on ricin activity, but such techniques are 
not specific to ricin and are shared with other ribotoxins. These approaches will be explored in more 
detail below. 
5.1. Enzyme-Linked Immuno-Absorbent Assay (ELISA)  
ELISAs to detect ricin have been around for at least 30 years and were first developed to replace the 
rather more cumbersome method of radioimmunoassay with the obvious hazard of dealing with 
radioisotopes [37]. The ELISA-based methods replaced radioimmunoassay and were developed in the 
1980s, with quite good limits of detection; for example, with a limit of detection for ricin of   
2 ng·100 μL
−1 of sample [28] which was superseded in our group by a method which had been made 
more sensitive through increasing the amount of enzyme linked to the target complex by the use of 
avidin-biotin immunoperoxidase complex in a “sandwich” of reagents [39]. This step increased the 
limit of sensitivity of the assay 100 fold, enabling us to detect 20 pg·100 μL
−1 in tissue extracts from 
rats poisoned with ricin, which had been treated to release the ricin for assay. This “sandwich” ELISA 
was used more recently to examine the fate of ricin following intratracheal instillation and   
ingestion [38]. Poli et al. used a similar approach [40] in human urine and plasma to quantify levels of 
ricin spiked into these matrices. They achieved limits of detection of around 100 pg ricin·100 μL
−1 Toxins 2011, 3 
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which could be improved to 10 pg·100 μL
−1 by increasing amounts of biotinylated antibody and   
avidin-linked enzyme in the assay, with good coefficients of variation; they also formulated a 
chemiluminescent assay with a similar performance. The “sandwich” ELISA format was   
employed [41] to detect ricin, also spiked into human urine and serum; here ricin was captured by an 
antibody raised against ricin B chain and reported by a monoclonal antibody directed against ricin A 
chain conjugated with peroxidase. This assay was reported to have a limit of detection below   
5 ng mL
−1 in buffer, and in a 10 fold dilution of urine or 50 fold dilution of serum. This format is still 
favoured for the analysis of ricin in animal tissues following poisoning [42].  
The detection of ricin in food, specifically ground beef, was achieved using electrochemiluminescence 
(ECL), which basically follows ELISA methodology, but the reporter antibodies were tagged using 
streptavidin with Ru(II) tris-bipyridine 4-methylsulfonate for an indirect assay [43]. ECL exploits 
multiple excitation cycles to amplify the luminescent signal and improve sensitivity. The mechanism 
of excitation and the relatively long emission wavelength (620 nm) potentially provide resistance to 
matrix effects, beneficial when interrogating complex materials such as fatty foods. Compared to 
ELISA, although the limits of detection were similar for both assays (0.5 ng ricin g
−1 for ECL and  
1.5 ng mg
−1 for ELISA), the ECL offers a wider dynamic range of operation, a lower coefficient of 
variation and less interference with complex matrices such as foods; the signal to noise ratio for the 
ECL was as much as five-fold better than the ELISA.  
The sensitivity of the ELISA-based assay format has been much improved by technical modifications, 
to enhance the limits of detection through amplification. The use of biotinylated reporter antibodies 
with avidinylated enzymes has already been shown to improve assay sensitivity 100 fold (39), but the 
combination of polymerase chain reaction (PCR) to amplify a DNA-labelled reporter system in place 
of an enzyme, is reported to achieve enhanced limits of detection into the femtogram per millilitre in 
human serum [44]. However, when this method was applied to the challenge of detecting ricin in 
complex food matrices [45], although a detection limit of 10 fg mL
−1 was achieved for ricin in PBS 
buffer, the limits were 10 pg mL
−1 in liquid egg and milk and 100 pg mL
−1 in ground beef. These are 
clearly superior to the ECL and ELISA methods. The same group used the immuno-PCR assay to 
detect ricin in murine sera and faeces and reported a limit of detection of 1 pg mL
−1 based on linear 
regression and 95% confidence interval [46]. 
5.2. Immunochromatographic Test Strips (Hand-Held Assays)  
Hand held assays are based on ELISA technology but use a lateral matrix, usually nitrocellulose, 
carrying an immobilised detection antibody across which flows a colloidal gold-labelled reporter 
antibody. Shyu et al. [47] reported the development of a rapid immunochromatographic test (ICT) for 
the detection of ricin, comprising two monoclonal antibodies, one directed against ricin B-chain and 
immobilised on the nitrocellulose and the other directed against ricin A-chain, labelled with nanometre 
sized colloidal gold particles. Sample solution for interrogation is added to an absorbent area, where it 
mixes with the gold-labelled anti A-chain antibodies. If ricin is present, it combines with this 
monoclonal, forming a complex, and this is captured by the immobilised anti B-chain antibody, where 
a visible red line develops. This assay could detect 50 ng mL
−1 of ricin in 10 min and the limit of 
detection can be increased up to 200 times following silver enhancement. An ICT was reported [48] 
for the diagnosis of inhalational ricin poisoning; this test has a rapid response time and a limit of Toxins 2011, 3 
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detection of 1 ng mL
−1. It was used to screen ricin samples prepared from 19 different cultivars or 
Ricinus communis and found to report them all equally well [49]. We have been examining the 
potential use of ICT for the diagnosis of ricin poisoning using body fluid samples from mice which 
have been exposed to ricin by inhalation. The tests do show some promise and, moreover, in comparison 
with the analysis of the samples using ELISA, ICT can be used semi-quantitatively if scanned using a 
densitometer and read against standards, often with good agreement with ELISA data. This study is 
soon to be reported. 
5.3. Immunoaffinity Columns 
The immunoaffinity column (IAC), which is also based upon antibodies for detection and reporting, 
functions like an ELISA in a column matrix. This approach offers the advantage of being able to cope 
with more dilute solutions of target antigen, as they may be applied to the column and absorb the target 
which builds up to a detectable concentration. The technique has been applied to the detection of 
different microorganisms and several toxins, but no reports have yet appeared for ricin detection. IAC 
have, however, been reported to have a sensitivity of one mouse lethal dose per mL for botulinum C 
and D in culture supernatants [50] and was found to detect 1 mouse lethal dose 50 per mL of 
botulinum A in a 5 mL sample of human serum [51]. In this latter report, the IAC test was also 
compared with an ICT to detect the same antigen, which was sufficiently sensitive to detect a human 
lethal dose of botulinum, but the IAC offered the advantage of being able to concentrate antigen if 
present in low concentration. Others have reported the application of the IAC to botulinum neurotoxins 
and E. coli 0157 in foods [52] and to the detection of Francisella tularensis in human samples (blood 
and urine) [53]. We are also applying this approach to the sensitive and rapid detection of ricin in body 
fluid samples with a view to making an early diagnosis of poisoning.  
From what we have seen in our observations, ICT offers potential for rapid diagnosis of ricin in a 
short time (<30 min) and is sensitive down to ng quantities. This rapid detection is very important 
because it is necessary to commence therapeutic strategies quickly, certainly within a few hours of 
exposure. The IAC technology is also very sensitive, again down to low nanogrammes, is fast (an 
answer in <1 h) and offers the advantage of being able to capture target in low concentration, by 
passage of several millilitres of sample through the column. Both techniques, therefore, have their 
merits in the defensive battery of tests leading to rapid diagnosis and speedy commencement of 
therapy for those exposed to the toxin.  
5.4. Surface Plasmon Resonance  
The final antibody-based technique to be mentioned here is surface plasmon resonance (SPR).   
In this technique, a thin layer of gold on a glass or quartz surface forms a mirror to reflect a laser 
generated light beam. Antibodies specific for ricin, for example, are adsorbed onto the gold surface. 
The angle of reflection of the light beam changes subtly when ricin in a solution travels past the 
immobilized antibodies, when they capture their target. The reflection is influenced by oscillation of 
electrons (plasmons) in the gold layer which are excited by the beam of light, causing less light to be 
reflected. When immobilised antibodies bind ricin, the refractive index of the gold surface changes; 
this alters the resonant frequency of the plasmons, which in turn further alter the amount of reflected Toxins 2011, 3 
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light. In essence, the detection is based on the fact that the adsorbing molecules cause changes in the 
local index of refraction, changing the resonance conditions of the surface plasmon waves. The method 
is very sensitive and the change in refractive index measured is directly proportional to the mass of the 
target molecule bound [54–56]. 
A whole range of toxins including Aflatoxin B1, Ochratoxin A, Fumonisin B1, Saxitoxin, 
Staphylococcal enterotoxin B, Tetanus toxin, and ricin or ricin A chain have been detected using  
SPR [57]. Rapid detection of ricin, at a concentration as low as 0.5 ng/mL [58], was achieved with a 
panel of immobilised monoclonal antibodies to detect ricin extracted from six horticultural variants. 
Portable SPR instruments are being developed for use in the field. One such instrument [59] could 
detect ricin at 200 ng/mL in 10 min. From a defensive angle, the use of SPR was engaged to screen 
food for the presence of a number of toxins including ricin as well as those which are common 
bacterial food contaminants [60]. The technique can also be used as a research tool and, in the case of 
ricin, has examined the binding properties of ricin and its B-chain (association constants) with 
immobilised glycolipids of varying chain length in phospholipid membranes [61]. SPR has also been 
used to investigate the interactions of carbohydrate inhibitors with Shiga-like toxin, a ribotoxin with a 
similar mechanism of action to ricin [62]. SPR is one of the assay technologies applied to the 
monitoring of the atmosphere for biological agents on a concentrated solution from continuous air 
sampling. Much emphasis is, therefore, placed on antibodies in the detection of threat agents. 
Generally speaking, antibodies form an invaluable tool both for the identification of ricin but also, they 
may be used therapeutically to mitigate the effects of ricin following exposure. One limitation of 
antibody-based techniques is that if a monoclonal antibody is employed, only one epitope is specified 
and this may be absent in the sample; polyclonal antibodies get around this problem but the chance of 
cross-reactivity with other antigens is increased, possibly making detection less specific. Further, 
antibody-based techniques do not necessarily provide an indication that the toxin is active and   
Kumar  et al. [63] have given examples where denatured ricin can still be detected by   
antibody-mediated tests.  
5.5. Polymerase Chain Reaction  
The isolation of ricin DNA from liquid egg and milk spiked with a ricin/acetone powder 
preparation, was achieved most effectively using acetyl trimethylammonium bromide and amplified 
using the real time polymerase chain reaction (RT-PCR) [64]. This shows that molecular biological 
methods can be applied to tests for ricin contaminated foods as counter-terrorist approaches.  
In a real situation with a “white powder” found in a hotel room in Las Vegas, RT-PCR was one of 
the methods which were successfully applied to identify ricin [65] in 2008; the test was supported 
using mass spectrometry. Others have reported the use of field-based RT-PCR [66] for the detection of 
ten threat agents, including ricin, without the need for sample extraction or purification. 
Other related studies using molecular biology have included an analysis of nucleotide 
polymorphisms associated with variants of the Ricinus communis plant grown around the world [67]. 
Genetic diversity amongst this group of plants was also examined by considering the genomes of 
seven diverse cultivars and comparing the data to a reference standard of a widespread cultivar,   
Hale [68]. The study focused on single nucleotide polymorphisms (SNPs).  Toxins 2011, 3 
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RT-PCR was also used in conjunction with immunodetection (see above) to enhance the limits of 
detection of ELISA type approaches using a DNA label in place of an enzyme.  
It is important to remember that RT-PCR will only be a viable option where crude ricin preparations 
are concerned. If ricin is highly purified, then it is very unlikely that there will be any nucleic acid 
material remaining in the preparation. However, since the internet recipes would all produce crude 
ricin, then this method of detection may offer additional benefits.  
5.6. Mass Spectroscopy  
The advantage of mass spectrometry in the identification of ricin is that it is based on   
physico-chemical properties of the protein itself and does not rely on antibodies. Providing that a fairly 
clean preparation of ricin can be made, this approach provides strong orthogonal evidence to support 
the identification of the toxin.  
Ricin has been characterised by electrospray mass spectrometry, capillary electrophoresis and 
surface plasmon resonance by Despeyroux et al. [69], using whole ricin molecules, as a means of 
studying the heterogeneity of ricin extracted from several different cultivars of Ricinus communis. 
However, the evidence provided is not conclusive identification of the toxin because it did not provide 
information linking with structural peptide backbone data. Fredriksson et al. [70] added this important 
development in their study by providing information on mass spectrosocopy of ricin at the amino acid 
and glycopeptide level. Ricin was prepared from seeds of several cultivars, denatured, reduced, 
digested by trypsin and analysed by high performance liquid chromatography followed by electrospray 
mass spectrometry using a Q-TOF tandem mass spectrometer. Ricin samples produced three ricin 
containing fractions after column chromatography (cation exchange) except for R. zanzibariensis, 
which produced only one ricin peak. After digestion and mass spectrometric analysis, sequences were 
compared to an amino acid sequence database. This analysis enabled ricin-specific trypsin digest 
peptides to be selected from the A and B chains of ricin which would enable the identification of ricin 
to be made in a single analysis run.  
Ricin enzymic activity was reported in a single step method with minimal sample preparation [71] 
which measured adenine release from DNA using real time mass spectrometry. Becher et al. [72] 
combined immunoaffinity capture using a ricin B chain-specific monoclonal antibody coupled to 
magnetic beads followed by the determination of adenine released by the active toxin from an RNA 
template by liquid chromatography tandem mass spectrometry (LC-MS/MS). The method, which was 
tested in milk, tap or bottled water, incorporates specificity and provides information on toxin activity 
with a limit of detection of 0.1 ng/mL with a low variability (10%). Although the full assay with this 
low limit of detection took twenty six hours to complete, a less sensitive response (3-fold lower) could 
be achieved in six hours.  
Kalb and Barr [73] described a three phase method to identify ricin in food or clinical samples 
(milk, apple juice, human serum or saliva). The approach comprised of the capture of ricin using 
immunoaffinity technology with antibody coated beads, a measure of activity of the toxin by probing 
depurination of a DNA substrate (using matrix-assisted laser desorption /ionization time-of-flight mass 
spectrometry; MALDI-TOF) and the analysis of tryptic peptides using LC-MS/MS. Together, these 
three components provided a sensitive and selective analysis and activity determination of ricin 
recovered from food or clinical samples. Another laboratory described a multiplex approach to the Toxins 2011, 3 
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detection of microbial and plant toxins [74] in complex sample matrices, in particular, with foods in 
mind (milk, apple juice and orange juice, ham and bacon rind). The method employed the affinity 
capture approach using toxin-specific antibodies coupled to paramagnetic beads, followed by trypsin 
digestion and the identification of toxin-specific fragments using MALDI MS. The approach   
identified ricin, SEB, Botulinum neurotoxins A and B, but further differentiated A1, A2, B, B1 and  
non-proteolytic B subtypes.  
At Dstl, ricin was detected in urine collected at between 8 and 12 h following exposure, in   
a murine model of intoxication by the intravenous route. Urine samples were separated using   
one-dimensional gel electrophoresis. Three key peptide sequences matching ricin and/or   
Ricinus agglutinin were subsequently identified by mass spectrometric analysis (LC-MS/MS) of a 
trypsin digest of the band appearing at approximately 60 kDa. Although only a preliminary 
investigation, this small study indicated the potential for this diagnostic approach [75].  
5.7. Activity Assays  
Assays for ribotoxins like ricin have been reported and were touched upon [71–74] in the mass 
spectrometry section above, when this method was used to probe the release of adenine by the   
N-glycosidase activity. Hale developed a microtitre plate based assay for the N-glycosidase  
activity expressed by ribotoxins based on the translation of luciferase mRNA. In samples containing 
active ribotoxin, luciferase mRNA was not translated and corresponding luminescence was   
decreased or absent [76]. Other approaches have reported measuring the enzymic activity using 
electrochemiluminescence [77], giving an assay which offered a similar level of sensitivity to that of 
an antibody based electrochemiluminescent assay (0.1 ng mL
−1). An alternative method, that of in vitro 
assay, tests the full activity of ricin including the binding to cells, uptake and expression of toxicity.  
One example of this approach is the use of monkey kidney Vero cells in a toxicity assay. In this 
report [78] these cells were used in culture to assess the efficacy of monoclonal antibodies against ricin 
to protect the cells from toxicity, as assessed using MTT, an assay based on mitochondrial function. In 
an alternative approach [79], Vero cells in cultur e  w e r e  u s e d  t o  a s s e s s  the inhibition of protein 
synthesis by manipulated ricin molecules using the incorporation of [
35S] methionine into cellular 
protein. There are opportunities to interrogate various aspects of cellular physiology or biochemistry 
following interaction with a toxic agent such as ricin, to probe the consequences of intoxication   
in detail.  
Defence against ricin toxin, therefore, involves an understanding of the hazards presented by the 
toxin when exposed by various routes and of the lesions resulting from exposure; this can help in the 
development of countermeasures against the toxin. If it is suspected that people may have been 
exposed to ricin, then it is essential to enable an early and robust diagnosis in order to start treating 
those who require appropriate therapeutic measures. To this end, we are testing the potential of 
immunoaffinity columns and immunochromatographic test strips, two quite rapid and sensitive assay 
systems, for supplying the necessary information. It is also important to be able to probe complex 
matrices such as foods in order to determine whether these have been contaminated with ricin. The 
best approach to ensure robust detection is to apply several orthogonal methods which are based on 
different criteria and this might include an antibody based test, a method based on the presence of Toxins 2011, 3 
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specific nucleic acid (DNA or RNA) and a mass spectrometric analysis. It should be apparent that 
there is ample specific technology available to provide an unequivocal answer to this challenge.  
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